Correlation Between Waters and Iteos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Waters and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Waters and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Waters and Iteos Therapeutics, you can compare the effects of market volatilities on Waters and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Waters with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Waters and Iteos Therapeutics.
Diversification Opportunities for Waters and Iteos Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Waters and Iteos is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Waters and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Waters is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Waters are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Waters i.e., Waters and Iteos Therapeutics go up and down completely randomly.
Pair Corralation between Waters and Iteos Therapeutics
Considering the 90-day investment horizon Waters is expected to generate 0.78 times more return on investment than Iteos Therapeutics. However, Waters is 1.28 times less risky than Iteos Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Iteos Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 38,721 in Waters on September 2, 2024 and sell it today you would lose (249.00) from holding Waters or give up 0.64% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Waters vs. Iteos Therapeutics
Performance |
Timeline |
Waters |
Iteos Therapeutics |
Waters and Iteos Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Waters and Iteos Therapeutics
The main advantage of trading using opposite Waters and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Waters position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.Waters vs. IDEXX Laboratories | Waters vs. IQVIA Holdings | Waters vs. Charles River Laboratories | Waters vs. Revvity |
Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |